D espite impressive progress over the past several decades, diseases of the heart remain the leading cause of death for US men and women, and coronary heart disease (CHD) accounts for the largest share of deaths within that category. CHD is particularly important in blacks due to the higher prevalence of major CHD 
Introduction
Research on CHD has contributed to the decline in cardiovascular disease morbidity and mortality that has occurred during the past three decades in the United States. However, life expectancy and rates of illness and death from CHD have not improved as much for blacks as for whites. Blacks have not experienced the full benefit of research advancements for a variety of reasons, including insufficient scientific data, lack of research focused on minority populations, and limited access to health care resources and technology. Consistent and universally accepted racial and ethnic categories have not been established, and definitions may vary according to the social and scientific context. The limited data base currently available leaves a number of paradoxes unresolved. Controversy remains regarding, in particular, both chest pain and sudden death. Available data indicate that the probability of dying from CHD is greater in black Americans than in white Americans and that there is a higher prevalence of smoking, hypertension, diabetes, obesity, and left ventricular hypertrophy (LVH) in blacks. Blacks are also less likely to receive coronary angiography or coronary revascularization.
The NHLBI Working Group on Research in CHD in Blacks assessed the state of the science and identified research opportunities in four main areas of CHD in blacks: pathogenesis and pathophysiological mechanisms; clinical expression, diagnosis, and treatment; disease patterns and risk factors; and behavioral variables and strategies for education and prevention. In its deliberations, the Working Group identified 10 priority research areas, which are, in order of research priority, treatment, epidemiology (data collection and analysis), evaluation of chest pain and diagnosis of CHD, prevention and behavior, risk factors, genetics, vascular biology, LVH, coronary microvasculature, and sudden cardiac death.
These research priorities are considered in four chapters of the full report: basic research, clinical research, population-based research, and behavior and prevention research. Each chapter reviews the state of the science and identifies opportunities and recommendations for future research directions.
Although most studies show that there is little difference in the nature of the atherosclerotic process leading to CHD in blacks, it has become evident that there are important differences in the social and economic con- text in which CHD develops in blacks. It is difficult to determine whether phenotypic characteristics common in blacks, such as high blood pressure and LVH, play a primary role in the pathogenesis of CHD in blacks or are merely markers for more fundamental differences in mechanisms of disease. It is not clear whether differences in the biology of CHD or in the clinical expression of common pathogenetic processes account for reported racial differences. Differences in access to cardiovascular care, the impact of risk factors, or Until the roles of access to care, knowledge and beliefs concerning CHD, coping styles and the social environment, and biological variables, such as cardiovascular reactivity, are clarified, understanding racial differences will be difficult. Culturally and ethnically appropriate techniques for individual and community behavior modification and lifestyle change, which would affect primary and secondary prevention of CHD, have not been developed specifically for blacks.
Risk Factors
The decline in CHD mortality and morbidity that began several decades ago, and continues to the present, has been coincident with widespread acceptance of the effectiveness of risk factor reduction in preventing CHD. The significant change in lifestyle and secular trends in risk factors that has occurred in the majority population has been less dramatic in blacks. Because prevalence rates of modifiable CHD risk factors, such as hypertension, cigarette smoking, physical inactivity, and obesity, have been documented to be greater in blacks than in whites, the opportunities for prevention may be greater for blacks.
Smoking rates in persons 18 years of age or older have declined in the general population but remain higher in blacks than in whites. Studies of leisure time physical activity suggest that blacks are more sedentary and less fit than whites, independent of income and education. Obesity, which is associated with hypertension, hyperlipidemia, hyperinsulinemia, and glucose intolerance, may be more common in blacks. The prevalence of obesity appears to be higher in black women than in patterns may differ slightly between blacks and whites, but foods selected by blacks and whites do not differ substantially in nutritional composition. Data in blacks are conflicting about the relation of elevated levels of lipoprotein(a) [Lp(a)], a genetically determined lipoprotein associated with CHD, to CHD risk. Increased left ventricular (LV) wall thickness is more common in blacks, even in the absence of hypertension. The contribution of LVH to risk of sudden death and out-ofhospital death in blacks is not clear.
Both individual and community-based interventions have been successful in modifying CHD risk factors in blacks, although individual approaches may be less effective in blacks than in the general population. Local church and communitywide education programs have been particularly effective in the control of hypertension and smoking in some black communities.
Genetics
The recent, unprecedented progress over the past decade in genetics and molecular and vascular biology has enhanced understanding of the pathogenesis of human disease. Although initial progress was made in diseases resulting from mutations of a single gene, methods are now available that allow investigation of complex diseases, such as atherosclerosis, hypertension, and disorders of coagulation. One prerequisite for studying complex diseases is identification of aggregates of patients or families with relevant phenotypic characteristics.
Family history comparisons between blacks and whites demonstrate a higher prevalence of positive family history of hypertension, stroke, diabetes, or obesity in black families. However, family history of CHD is similar among black and other populations. Black families also appear to be similar to other populations in having strong correlations for major CHD risk factors between biological relatives but not with unrelated persons living in the same household.
Complex Greater understanding has been gained of the interaction of the vascular endothelium and the vessel wall with specific cellular elements in blood; the function and composition of specific lipoproteins, enzymes, hormones, and receptors; the contribution of genetic and immunological factors; the impact of alterations in the autonomic nervous system; and the role of coagulation and thrombosis in atherogenesis and the coronary syndromes. It is not known, however, whether there are significant racial differences in the cellular and molecular mechanisms of atherogenesis. LVH Research on CHD in blacks presents a unique challenge because of the increased prevalence of LVH and hypertension in the black population. In studying CHD in blacks, LVH and hypertension may be confounding factors, challenging investigators to identify the separate and common pathogenetic mechanisms of atherosclerosis, hypertension, and LVH and to explain their interaction. LVH has been shown to be an important risk factor for CHD, sudden death, and congestive heart failure, and it confers significant risk for future cardiovascular events, independent of atherosclerotic disease in the epicardial coronary vessels. Many of the pathogenetic features of LVH, such as endocrine, paracrine, and autocrine factors, can now be studied in humans.
Because hypertension is common in blacks, the increased prevalence of LVH in blacks is often attributed to concurrent hypertension, but young blacks tend to have increased LV wall thickness compared with whites, even in the absence of increased blood pressure. Cardiac myocytes constitute 75% of the heart mass, and the interstitium comprises 25%. Hypertension is the major stimulus to myocyte hypertrophy. Studies The research recommendations proposed by the Working Group are described in detail in the four main sections of its report. In developing these recommendations, the Working Group identified an overriding need in all areas of research on CHD in blacks for a comprehensive data base of information and a coordinated network of clinical researchers. Therefore, the Working Group strongly recommends the establishment of a centralized data base of existing data on CHD in blacks. Such a data base will be an important resource for planning and conducting future research studies of acute and chronic coronary syndromes in blacks. The Working Group also strongly recommends support for a comprehensive, multidisciplinary, national network of investigators in community-based clinical centers. Through this national network, clinical researchers will be able to collect and coordinate prospective data on environmental and behavioral determinants of CHD in blacks; clinical characteristics, disease course, and epidemiology of acute and chronic CHD syndromes in blacks; variations in cardiac care; and the extent and causes of differences between black and nonblack populations in the use of cardiac procedures.
Implementation of these two major recommendations of the Working Group will accelerate research on CHD in blacks and research findings that will be relevant to all US populations. The data base and clinical network are necessary steps to the future, integrating existing fragmentary and incomplete data and encouraging coordinated research in pursuit of well-planned hypotheses.
The Working Group's recommendations for each of the 10 research areas, listed in priority order, are summarized below.
Treatment
Disparities in health outcomes of CHD in blacks, compared with whites, may result from differences in risk factor profiles, use of diagnostic tools, management of acute and chronic CHD syndromes, and access to revascularization procedures. Research should be expanded to identify the most effective means of increasing awareness about the value of reducing risk factors and treating symptoms and signs of CHD in black populations. The causes of differences in clinical characteristics and outcomes of CHD between blacks and whites also need to be determined.
Although reduction in the development of stroke attributable to control of hypertension has exceeded that predicted from epidemiological studies, reduction in CHD related to antihypertensive treatment has been much less striking. Given that hypertension is more common in blacks than in whites, studies should be conducted to define the possible contribution of antihypertensive therapy to mortality from CHD in blacks.
crucial insights that will allow similar improvement in The prevalence of heart failure related to CHD is increasing as more patients survive acute coronary syndromes. Heart failure due to CHD or ischemic cardiomyopathy is now one of the most common diagnoses prompting hospital admission. Heart failure is more prevalent in blacks, perhaps because of coincident hypertension or diabetes mellitus. Research comparing ventricular dysfunction due to macrovascular versus microvascular disease and atherosclerotic versus nonatherosclerotic disease is needed, especially in blacks.
Ischemic cardiomyopathy is one of the major contributors to heart failure leading to cardiac transplantation. Studies are needed to determine more effective drug therapy for both systolic and diastolic dysfunction. The appropriateness and value of CABG surgery, PTCA, and thrombolysis, compared with conventional medical therapy, also need to be assessed. For this effort, existing data from multicenter interventional trials should be pooled as appropriate, and prospective clinical trials of various revascularization approaches should be conducted in blacks and compared with existing data in whites. Epidemiology (Data Collection and Analysis) The fundamental obstacle in studying CHD in blacks is the absence of sufficient data for resolving many of the questions related to racial comparisons. Because information is limited for specific racial and ethnic groups, determining whether differences and inconsistencies are due to chance findings, artifacts in reporting, or important genetic and biological factors is a difficult, but not insurmountable, problem.
Data collected previously from large clinical trials, national surveys, and vital statistics sources have not been analyzed collectively. When integrated, they may contain valuable information on CHD in blacks. By merging national and regional data on CHD in blacks, it will be possible to obtain a more complete picture of the effectiveness of therapeutic interventions, determinants in the use of cardiological care and resources, medical practice patterns, and outcomes of hospital and ambulatory services. Based on these data, research needs and information gaps can be further clarified, and plans for future analyses of prospectively collected data can be formulated.
In conducting research on CHD in blacks, it is important to distinguish health-related consequences of social and economic factors from biological or genetic processes that may be active in the pathogenesis, clinical expression, and outcomes of CHD in blacks. The appropriate use of racial categories in biomedical research should be defined and the limitations of these categories well understood. Studies of the magnitude of betweengroup genetic differences and within-group heterogeneity should be given high priority. Caution must be exercised in interpreting differences between population subgroups so that the contribution of genetic factors, such as race, is not overemphasized. The distinctive roles of environmental forces, such as socioeconomic status and stress related to minority status, and the genetics and biological aspects of race should be clarified.
Evaluation of Chest Pain and Diagnosis of CHD
The clinical evaluation of chest pain continues to challenge the diagnostic acumen of many clinicians. Accurate diagnosis of CHD in blacks may be more demanding because of the more common concurrence of hypertension, LVH, or both. How this information affects the diagnostic approaches of clinicians is not clear. It is known, however, that blacks receive cardiac procedures, both diagnostic coronary angiography and revascularization, less commonly than whites.
It is not clear whether this disparity between blacks and whites is a function of physician factors, limited access to health care, or individual health-care-seeking behavior. Providers may vary in their ability to convey educational messages to culturally diverse patient populations. Research on the roles of these factors is recommended.
Studies are also needed to compare the decisionmaking process by health care providers for ordering diagnostic procedures in blacks and whites and the role of patient preferences in choosing to accept recommended procedures. The relative roles of risk factors, disease severity, and other variables should be compared with the impact of race and socioeconomic status on the use of cardiac procedures in blacks.
Additional new and improved noninvasive techniques for monitoring the development, progression, and regression of CHD and LVH in blacks need to be developed. The implications of ECG findings considered to be normal in blacks should be reassessed, given the data indicating that out-of-hospital deaths and sudden death may be more common in blacks. Comparison of the relative value of imaging techniques for assessing CHD risk in blacks with signal-averaged ECG and other evolving noninvasive techniques should be undertaken. Also important is comparison of the relative value, reliability, accuracy, sensitivity, and specificity of noninvasive diagnostic techniques, such as ECG, echocardiography, stress testing (in conjunction with ECG, echocardiographic, or radionuclide imaging), nuclear magnetic resonance, and positron emission tomography in blacks and whites. The applicability of these tests to individuals with atherosclerotic and nonatherosclerotic CHD, and with hypertension and/or LVH, should be compared in blacks and whites.
Research establishing the role of genetics in some forms of LVH suggests the need to determine the value of echocardiography and other imaging techniques, compared with genetic testing, in diagnosing individuals with genetically determined LVH or hypertrophic cardiomyopathy. Clinical trials will be important in evaluating the value of new and improved noninvasive diagnostic tools, such as intravascular ultrasound and threedimensional echocardiography, in assessing ventricular structure and function and the physiology of the macrovasculature in blacks and whites.
The reasons for the paradoxically high rates of normal coronary angiographic findings in blacks with angina-like chest pain need to be elucidated. Also, given that individuals who enter angiographic trials may not be representative of the general black population, methods need to be developed to assess and control for selection bias in angiographic studies of blacks. Investigators LVH may also predispose to ventricular arrhythmias in blacks. The role of intracellular ionic and metabolic changes in initiating and maintaining a reduced threshold for ventricular fibrillation and complex ventricular tachyarrhythmias needs to be determined, and studies of the racial differences in these factors are recommended. Researchers are encouraged to use human biopsy specimens to delineate subcellular changes in the sarcolemma, sarcoplasmic reticulum, and contractile apparatus that may account for changes in intracellular calcium handling and excitation-contraction coupling that occur in LVH.
Valid and reliable noninvasive techniques should be developed for assessing the regression of LVH and its impact on the course of CHD in blacks. Experimental models are also needed for studying the role of hemodynamic, nonhemodynamic, and growth factors in development of LVH.
Coronary Microvasculature
Abnormalities of the coronary microvasculature have been proposed to explain the paradoxically high prevalence of normal-appearing epicardial vessels on angiography in patients with angina-like chest pain. However, the nature and pathogenesis of coronary microvascular disease have not been studied extensively in humans, and data in animals are relatively sparse compared with Investigations of the mechanisms that control microvascular function and structure, including endothelial function, intracellular ions, and vascular reactivity, are recommended. Interactions among endothelial, neural, and hormonal control of microvascular tone and coronary blood flow should be clarified using both animal and human vessels. The relative importance of the various control mechanisms in blacks and whites should be determined in in vitro microvascular reactivity profiles and how they are affected by CHD and hypertensive LVH. Studies of coronary vasodilator reserve in animal models (eg, the pig model) using positron emission tomography, nuclear magnetic resonance, or other imaging technologies may also be useful in assessing the determinants of microvascular function.
New and improved techniques are needed for human studies of the microvasculature and measurement of coronary reserve and microcirculatory flow in blacks with atherosclerotic and nonatherosclerotic CHD. The influence of inflammation, vasculitis, or immune complex disease on abnormal coronary reserve, microvascular function, and chest pain syndromes in blacks should be assessed. Also needed are investigations of the impact of controlling CHD risk factors, such as hyperlipidemia, LVH, diabetes, and smoking, on chest pain and the natural history of microvascular disease.
Further studies are recommended on the impact of microvascular disease on ventricular function and heart failure in blacks with angina-like chest pain and normal coronary arteries. Microvascular function should be compared in different vascular beds (ie, forearm versus heart), and studies are needed on the relation of abnormal microvasculature in different vascular beds to the signs and symptoms of CHD.
Sudden Cardiac Death
Although recent data suggest that out-of-hospital and sudden death rates are higher in blacks, much of these data are derived from local studies and have not been confirmed in broader populations. The incidence and prevalence of life-threatening arrhythmias need to be determined in blacks with chest pain syndromes related to nonatherosclerotic and atherosclerotic CHD. The relation of differences in cardiovascular reactivity to racial variations in sudden death and case-fatality rates in blacks and whites also should be explored.
Studies of diurnal variation in sudden death and other cardiac events are needed to identify the endocrine, paracrine, or autocrine factors that are most important in the pathogenesis of these events. Criteria for identifying individuals at high risk of arrhythmias and sudden death should be validated in blacks. Investigations are also needed on the relation of traditional risk factors (eg, LVH, hypertension, hyperlipidemia) and behavioral and environmental factors to the risk of sudden death and lifethreatening ventricular arrhythmias. 
